Download - Laporan Praktikum Farmakoterapi II p.1 Ggk
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
1/21
LAPORAN PRAKTIKUM FARMAKOTERAPI II
PENYAKIT CRF DENGAN ASCITES
Disusun oleh:
1. WILDATUS SOLIA !G1F"1#""$%
#. SYNTIA APDA&UNA PUTRI !G1F"1#"1#%'. NO(IANTI DIAN LESTARI !G1F"1#"#"%$. ISANTI DWI RAAYU !G1F"1#"#)%*. DE(A EFA AFILA !G1F"1#"'+%+. GINAN&AR WAYU R. !G1F"1#"$$%,. DORIS DE--Y C. S. !G1F"1#"*#%). ANITA KURNIA !G1F"1#"+"%. WAYU NUNGGAL P. !G1F"1#",#%1". AFIA RO-ITO !G1F"1#")"%11. PUTRI MARGARETA !G1F"1#"))%
Dosen Pe/0i/0in : Tunul A2i P.3 M.S4.3 A56T7n7l Dis8usi Dosen : Sel7s73 , A59il #"1*
N7/7 Asis6en : K78 Ti7T7n7l Dis8usi Kelo/5o8 : '1 M79e6 #"1*
LA-ORATORIUM FARMASI KLINIK&URUSAN FARMASI
FAKULTAS ILMUILMU KESEATANUNI(ERSITAS &ENDERAL SOEDIRMAN
#"1*CRF DENGAN ASCITES
A. KASUS
1) I2en6i67s P7sien
N7/7 P7sien Ds9 U/u9;TTL *' 67hun
No. Re87/ Me2i8 ,#))#+ --
Al7/76 Pelu67n T-
S676us &7/in7n &e/8es/7s &enis Kel7/in L78il78i
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
2/21
#% Ri
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
3/21
7
$% D767 L70o976o9iu/
Pe/e9i8s77n S76u7n T7n7l
1,;1 1);1 1;1 #";1 #1;1 ##;1 #';1
K //ol;L *3$
C7 /;2L ,3+
0 ;2L 3# )3* 113
Leu8osi6 ;uL 1*+," 1'$$" 1#"" '$"""
CT #* #$ '$
E9i69osi6 1"+;uL '3$ '3# $3#
MC( >l ,$31 ,$3'
MC 5 #+3) #+3+
RDW 1$3, 1$3
Eosino>il 13' 1
-767n "3"" "3"" "3"
Se/en ))3$ )*3' "3""
Li/>osi6 ))3$ )*3' ),3#
Monosi6 13 1"3#
To6. P9o6ein ;2L )3,
Al0u/in ;2L '3")
Glo0ulin ;2L *3+#
SGOT u;L *1
U9eu/2797h
/;2L 1,3, 1)#31 1*)3$
SC9 /;2L 1'3#$ 113'# 1"3$#
*% Pe/e9i8s77n PenunB7n
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
4/21
N7/7Pe/e9i8s77n:
7sil
EKG !?%Puns As4i6es !?%T7n7l:
1);"1;#"1'
+% Te975i
O076 Dosis F9e T7n7l
1,;1 1);1 1;1 #";1 #1;1 ##;1 #';1
O# $ l5/
In> D* 1" 65/ 1" 65/
InB A/5i4illin 1 9
InB L7si #A i
InB R7n6in 1A i # /l*" /
-i4n76 # >l7sh29i5 27l7/ D**"" 44
In1).#$.!# seh79i%*" /
A/lo2i5in 1" /670 1)#$B7/
!1 seh79i%
D
P9o T97ns>usiPRC
# 197/
Ce>69i7on i
N7/7Pe/e9i8s77n:
7sil
EKG !?%
Puns As4i6es !?%T7n7l:
1);"1;#"1'
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
5/21
,% Te975i S776 KRS
N7/7 O076 Dosis F9e8uensi &u/l7h
-. DASAR TEORI1. PATOFISIOLOGI
Patofisiologi Gagal Ginjal Kronik
G77l inB7l 89oni8 /e9u5787n 5enu9un7n l7Bu >il697si 2i
lo/e9ulus3 h7l i6u 2ise07087n 879en7 6e927576 576oen 767u 0is7 6e9B72i
879en7 2i70e6es /elli6us3 sel7in i6u 0is7 Bu7 6e9B72i 879en7796e9ios4le9osis. &i87 77l inB7l 2ise07087n oleh 576oen3 /787 576oen
6e9se0u6 787n /e9us78 lo/e9ulus sehin7 l7Bu >il697sin=7 /enB72i
6u9un. &i87 77l inB7l 2ise07087n oleh 2i70e6es /elli6us Bu7 787n
0e927/578 s7/73 =7i6u 787n /e9us78 lo/e9ulus 27n l7Bu >il697sin=7
/enu9un3 h7l ini 2ise07087n 879en7 87279 ul7 2797h 5727 57sien
2i70e6es le0ih 6ini 279i5727 57sien =7n 6i278 /en2e9i67 2i70e6es3
se/en6797 inB7l /e/5un=7i 0767s7n 6e9sen2i9i un6u8 /en=79in ul72797h. Pen=e070 l7in =7n /en=e07087n 77l inB7l 89oni8 =7i6u
796e9ios4le9osis. A96e9ios4le9osis /e9u5787n 8e9us787n 5727 796e9i3
sehin7 7li97n 2797h 8e lo/e9ulus /enB72i 6u9un. 7l i6u /en=e07087n
5enu97n7n 5727 27e97h >il697si =7n /en=e07087n 5e9u07h7n 7li97n
2797h sehin7 7li97n 2797h 2i lo/e9ul79 787n /enin876 27n 6e87n7n 2i
875ile9 lo/e9ulusn=7 /enin8763 8e6i87 6e87n7n 2i 875ile9 /enin8763
/787 5e9/e70ili67sn=7 /enB72i 8u97n sehin7 59o6ein59o6ein =7n
seh79usn=7 6e967h7n 2i lo/e9ulus /enB72i /7su8 8e inB7l. A27n=7
59o6ein 2i 27l7/ inB7l ini 0e9si>76 ne>9o6o8si8 !se/78in /e9us78 inB7l%3
sehin7 787n 6e9B72i 59o9esi 8e9us787n inB7l.
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
6/21
!Di5i9o ,6h e23 #"")%.
Hubungan Patofisiologi Ascites-CKD-Sirosis Hati
Ke/un8in7n /e87nis/e 6e9B72in=7 hu0un7n 7n6797 CKD
As4i6esSi9osis 727l7h P7sien 5727 7unsi un6u8 /enh7sil87n 59o6ein =7n seh79usn=7 727
5727 2797h. -e98u97nn=7 olu/e si98ul7si ini 6e9B72i 879en7 59o6ein
5727 2797h 0e98u97n !2797h en4e9%3 sehin7 6u0uh 787n 0e9us7h7
/el78u87n 8o/5ens7si 0e9u57 5enin8767n sis6e/ RAAS 779 olu/
6u0uh /enB72i no9/7l. A8i076 8e9B7 inB7l =7n 0e9le0ih7n3 inB7l 787n/en7l7/i 5enu9un7n GFR 27n suli6 un6u8 /ene8s89esi87n u9ine3
u9eu/3 hi5on769e/i73 2ll.
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
7/21
(DAPUS).
#. GUIDELINE TERAPI
!&NC )3 #"1$%.
P727 57sien =7n 6e98en7 hi5e96ensi 5e9lu 2il78u87n 5e907i87n
7=7 hi2u5 se5e96i ol7h 977 6e976u93 /e/5e907i8i 5ol7 /787n =7n
0e96uBu7n un6u8 /enu9un87n 6e87n7n 2797h =7n /enin876. Den7n
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
8/21
/e/in7lisi9 un6u8 6e98en7n=7 2i70e6es 27n CKD 5727 5en2e9i67
i5e96ensi. &i87 57sien /en7l7/i hi5e96ensi s7B7 67n57 727n=7 5en=78i6
l7in se5e96i 2i70e6es 27n CKD 5727 usi7 8u97n 279i +" 67hun /787
6e87n7n 2797h se07i8n=7 S-P 1*" // 27n D-P " //. &i87
5727 57sien 2en7n usi7 le0ih 279i +" 67hun 6e87n7n 2797h se07i8n=7 S-P
1$" // 27n D-P " // 779 6i278 6e9B72i i5e96ensi. &i87
57sien /en7l7/i hi5e96ensi 27n 2i70e6es -loo2 59essu9e o7l S-P 1$"
// 27n D-P " //3 se27n87n 5727 57sien hi5e96ensi 2en7n
CKD -loo2 59essu9e o7l S-P 1$" // D-P " //. Pe/0e9i7n
6e975i un6u8 57sien =7n 6e98en7 hi5e96ensi 2i0e9i87n 6e975i 2en7n
2iu9e6i8 Benis 6hi7Hi2e 27n ACEI 767u AR- 767u CC-3 2en7n 5e/0e9i7no076 se4797 sen2i9isen2i9i 767u 27l7/ 8o/0in7si. Se27n87n 5727 57sien
=7n /en7l7/i hi5e96ensi 27n 2i70e6es 2i0e9i 2iu9e6i8 Benis 6hi7Hi2e 767u
CC- s7B7 767u 27l7/ 8o/0in7si. P7sien 2en7n hi5e96ensi 27n CKD 2i0e9i
6e975i ACEI 767u AR-3 2en7n 5e/0e9i7n o076 se4797 sen2i9isen2i9i 767u
27l7/ 8o/0in7si 2en7n o076 olon7n l7in. Un6u8 /en2757687n h7sil
=7n le0ih 07i8 2il78u87n 0e0e9757 s6976ei un6u8 6e975i o076n=7:
7% M78si/7l87n o076 6e9le0ih 27hulu se0elu/ /en7/07h87n 8e2u7 767u
0% T7/07h o076 8e2u7 se0elu/ /en4757i 2osis /78si/u/ o076 5e967/7
767u
4% Mul7i 2en7n # 8el7s o076 se4797 6e95is7h 767u se077i 8o/0in7si
2osis 6e675.
7l 6e9se0u6 0e0e9757 h7l =7n 5e9lu 2i5e9h76i87n /en2757687n h7sil =7n
le0ih 07i8. Un6u8 /e/5e98u76 5eno0767n 27n 8e576uh7n 7=7 hi2u5.
Un6u8 s6976ei A 27n -3 /en7/07h 27n 2iu9e6i8 Benis 6hi7Hi2e 767u ACEI
767u AR- 767u CC- !5enun77n 8el7s o076 =7n se0elu/n=7 6i278
2i5ilih 27n /enhin279i 5enun77n 70un7n ACEI 27n AR-%. Un6u8
s6976ei C3 6i697si 2osis o076 7
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
9/21
8el7s o076 !e3 0lo48e93 7n67onis 7l2os6e9on3 767u o97n l7in% 27n 767u
/e9uBu8 8e 2o86e9 2en7n 8e7hli7n 27l7/ /7n7Be/en hi5e96ensi. Pe9lun=7
2il78u87n 69e76/en6 6e9se0u6 2en7n 07i8 27n /e/oni6o9in o076 2en7n
sesu7i !&NC )3 #"1$%.
C. PENATALAKSANAAN KASUS DAN PEM-AASAN1. SU-&EKTIF
N7/7 P7sien : D7so9iAl7/76 : Pelu67n
No RM : ,#.))#+U/u9 : *' 6hn--;T- :
S676us &7/in7n : &7/8es/7sMRS : 1,;"'#"1'KRS : #';"'#"1'Ri
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
10/21
-AK l7n4
79
L7n4
79-A-
Mu7l ?Pe9u6
0es79
!he9ni
7%
?
!A8h/72i3 #"1$%Ke6e97n7n: TD F786o9 =7n /e/5en79uhi 6e87n7n 2797h =7i6u 6e87n7n 5e/0uluh
2797h 6e5i3 olu/e 2797h 6o67l3 is8osi67s 2797h 27n 8elen6u97n 2in2in
796e9i. P797/e6e9 =7n 2iu8u9 727l7h 6e87n7n /78si/7l 5727 2in2in 796e9i
sel7/7 8on6978si e96i8el 8i9i. N72i P7sien /en7l7/i 678i8792i73 =7i6u 2en=u6 B7n6un 4e576 le0ih 279i
nil7i no9/7l. -i7s7n=7 6e9B72i 5727 57sien =7n 2e/7/3 >eo89o/osi6o/73
4ones6i> he796 >7ilu9e3 s=o8 hi5oole/i83 79i6/i7 8o92is3 5e47n2u 8o5i 27n
9o8o8. RR L7Bu 5e9n7>7s7n /enin876 5727 8e7277n s69ess3 8el7in7n /e670oli83
5en=78i6 B7n6un 579u. Suhu Suhu 6u0uh 2i5en79uhi oleh i97/7 si9872i7n3 usi73 Benis 8el7/in3
s69ess3 suhu lin8un7n3 ho9/on 27n ol7h977. Suhu 6u0uh /en4e9/in87n
8esei/07n7n 7n6797 5e/0en6u87n 27n 5enelu797n 57n7s. Pus76
5en76u97n suhu 6e927576 2i hi5o67l7/us3 0il7 suhu 6u0uh /ele0ihi suhu
no9/7l3 /787 5enelu797n 57n7s /enin876 27n se07li8n=7 0il7 suhu 6u0uh
9en27h !A8h/72i3 #"1$%. Ses78 n7>7s 2ise07087n 879en7 7nu7n i97/7 B7n6un !RR% Le/7s 2ise07087n 879en7 sus7h -A- Mu7l 2ise07087n 879en7 8e7277n u9e/i8 !87279 u9e7 27l7/ 2797h =7n
/enin876% Sus7h -A- 2ise07087n 879en7 8e8u97n7n 47i97n. Pe9u6 /e/0es79 879en7 sus7h -A- !S7n6os73 #"",%.
Pe"eriksaan !ilai
!or"al
Tanggal Keterangan
#$%# #&%# #'%# %# #%# %# *%#
K '3) J * *3$ No9/7l
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
11/21
//ol;L
C7 )3) J1"3$
/;2L
,3+ Tu9un !1,;1%
0 1# J 1+3*;2L
3# )3* 113 Tu9un!1,31)3#";1%
Leu8osi6 '#"" J1"""";uL
1*+," 1'$$" 1#"" '$""" Menin876!1,31)3#"3##%
CT '* J *" #* #$ '$ Tu9un!1,31)3#";1%
E9i69osi6 '3) J *3+1"+;uL
'3$ '3# $3# Tu9un!1,31);1%
MC( )" J 1"">l
,$31 ,$3' Tu9un!1,31);1%
MC #+ J '$5
#+3) #+3+ Tu9un!1,31);1%
RDW 1$3* 1$3, 1$3 Menin876
!1,3 1);1%
Eosino>il "* 13' 1 No9/7l
-767n #+ "3"" "3"" "3" Tu9un3in2i87siin>e8si
Se/en *"," ))3$ )*3' "3"" N7i83in2i87siin>e8si
Li/>osi6 #"'* ))3$ )*3' ),3# Tu9un3in2i87siin>e8si
Monosi6 #) 13 1"3# N7i83in2i87siin>e8si
To6. P9o6ein +3')3);2L
)3, No9/7l
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
12/21
Al0u/in '3)*3$;2L
'3") Tu9un3hi5o7l0u/in
Glo0ulin #3+'3+
;2L
*3+# N7i8
SGOT ', u;L *1 N7i838e9us787nh76i
U9eu/ 2797h *#*/;2L
1,3, 1)#31 1*)3$ N7i837si2osis/e670oli8
SC9 "3*13#
/;2L
1'3#$ 113'# 1"3$# N7i83 >unsi
inB7l/enu9un
!Ke/en8es RI3 #"11%.
Ke6e97n7n: CT;e/76o89i6 /enunBu87n 5e9sen67se sel 2797h /e97h 6eh7275 olu/e
2797h 6o67l. Penu9un7n nil7i 46 /e9u5787n in2i876o9 7ne/i7 !879en7
0e9077i se070%3 9e78si he/oli6i83 leu8e/i73 si9osis3 8ehil7n7n 07n=78
2797h 27n hi5e96i9oi2. Penu9un7n 46 se0es79 '" /enunBu887n 57sien/en7l7/i 7ne/i7 se27n hin7 5797h.
-;e/olo0in 727l7h 8o/5onen =7n 0e9>unsi se077i 7l76 697ns5o967si
o8sien !O#% 27n 8790on 2io8si27 !CO#%. Penu9un7n 59o6ein 0 no9/7l
6i5e A13 A#3 F !>e67l% 27n S 0e9hu0un7n 2en7n 7ne/i7 sel s70i6. Bu/l7h
he/olo0in 8u97n 279i 1# /;2L /enunBu887n 7ne/i7. Nil7i leu8osi6 =7n s7n76 6ini !2i 767s #".""";//'% 27576 2ise07087n
oleh leu8e/i7. Pen2e9i67 87n8e9 5os6o5e97si !se6el7h /enB7l7ni o5e97si%
/enunBu887n 5ul7 5enin8767n leu8osi6 e8si. E9i69osi6 /enu9un 879en7 5enu9un7n >unsi inB7l C7;i5o87lse/i7 27576 2i78i07687n oleh hi5e9>os>76e/i73 7l87losis3
os6eo/7l7si73 5en7n6i7n 87lsiu/ =7n 6i278 /en4u8u5i3 5enun77n
l78s76i>3 >u9ose/i2e3 27n 5e/0e9i7n 87lsi6onin. Pseu2ohi5o87lse/i7
8727n8727n 2i6e/u87n 0il7 8onsen697si 7l0u/in 9en27h 879en7 727n=7
70un7n 87lsiu/ 2en7n 7l0u/in
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
13/21
Penu9un7n nil7i MC( 6e9lih76 5727 57sien 7ne/i7 8e8u97n7n 0esi3
7ne/i7 5e9nisios7 27n 67l7se/i73 2ise0u6 Bu7 7ne/i7 /i89osi6i8. Penu9un7n MC /enin2i87si87n 7ne/i7 /i89osi6i8 !Ke/en8es RI3
#"11%. Penin8767n RDW 27n MC( 6u9un3 2i87i687n 2en7n 8e6en6u7n se077i
0e9i8u6: Ke8u97n7n H76 0esi3 S70i6 sel6h7l7sse/i7. Li/5osi6 : S7n76 Tu9un3 879en7 s7l7h s76u leu8osi6 =7n 0e95e97n 27l7/
59oses 8e8e07l7n 27n 5e/0en6u87n 7n6i0o2i3 5enu9un7n li/5osi6 =7n
s7n76 9en27h 6e9B72i 5727 5en2e9i67 77l inB7l. Monosi6 : /enin876. Penin8767n /onosi6 6e9B72i 879en7 in>e8si i9us3
5797si6 !/is7l87n 474in%.
SGOT : Menin876. Penin8767n SGOT 6e9B72i 879en7 727n=7 9727n o6o6B7n6un3 si9osis he576i6is3 27n in>798 579u.
S49 : S7n76 /eni876. Penin8767n S49 27l7/ 2797h 6e9B72i e8s89esi
/el7lui s7lu97n 4e9n7. -767n : Menin876 879en7 in>e8si 0786e9i Se/en : Menin876 879en7 in>e8si 0786e9i 27n i9us. U9eu/ 2797h : Menin876. K7279 u9eu/ 2797h 4e576 /enini 279i 5727
49e76inin 0il7 >unsi inB7l 9us78. Al0u/in : Tu9un
Al0u/in 879en7 2i0u76 oleh h76i3 /787 5enu9un7n 7l0u/in se9u/27576 /en=e07087n 279i 5en=78i6 h76i 89oni83 inB7l3 s7lu97n 4e9n7
89oni8327n in>e8si 6e96en6u. Penu9un7n 7l0u/in se9u/ 27576 /en=e07087n
47i97n 0e95in27h 279i 27l7/ 5e/0uluh 2797h /enuBu B79in7n sehin7
6e9B72i e2e/7. Glo0ulin : Menin876
Glo0ulin /e9u5787n s7l7h s76u >978si u67/7 59o6ein 27l7/ 2797h.
-e9un7 un6u8 si98ul7si ion3 ho9/on 27n 7s7/ le/78. -e0e9757 Benis
lo0ulin /eni876 he/olo0in3 0e0e9757 l7inn=7 /eni876 H76 0esi30e9>unsi un6u8 /el7e8si3 27n 0e96in278 se077i >786o9 8o7ul7si.
Pe/e9i8s77n 2797h =7n 2i7nBu987n 5727 GGK 727l7h 87279 se9u/
89e76inin 27n 0loo2 u9e7 ni69oen !-UN%. I7 727l7h 5e/e9i8s77n =7n
0i7s7 2il78u87n un6u8 /oni6o9 8el7in7n inB7l. P9o6ein 89e76inin 727l7h
h7sil 2e9727si no9/7l o6o6 27n u9e7 727l7h h7sil 78hi9 /e670olis/e
59o6ein. 7sil 8e2u7n=7 /enin876 27l7/ 2797h Bi87 727n=7 57n=78i6 5727
inB7l.
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
14/21
'. ASSESSMENT
P9o0le/ Me2i8 Te975i Assess/en6 Re8o/en27siLeu8osi6
/enin876
A/5i4illin i. 1
97/;h79i
In>e8si
-u6uh
5en=esu7i7n 2osis
#*" / 5e9 o97l
se6i75 1# B7/
!796/7n e6 7l3
#"1"%.Pe9u6 0es79
!he9ni7%3
Pe/e9i8s77n
5uns 7si6es !?%
L7si #A i. Asi6es
O076 6i278 e>e86i>3
6e927576 6e975i
=7n le0h e>e86i>
Menun787n
579es6esis
!il6ono%.
Mu7l R7n6in 1A i.5727 67n7l
1,;1;1' 27n
1;1;1'
Te975i 6i2782i5e9lu87n3 6i278
727 in2i87si
Pe/0e9i7nn=7h7n=7 2i0e9i87n
5727 67n7l
1);1;1'
$. PLANa. Tujuan tera+i
1% Menin87687n 8u7li67s hi2u5 57sien#% Men4e7h 8o/5li87si CRF !T%
'% Menelu7987n 47i97n 7si6es 2en7n parasitesi (ngga tau namanyaapa)s
$% Men7n6i87n >unsi 8e9B7 inB7l 2en7n he/o2i7lis7*% Menu97ni 59oesii67s 8e9us787n inB7l
b. Tera+i !on-,ar"akologi
1% Mene97587n 7=7 hi2u5 seh76#% Mel78u87n ol7h977 9in7n se4797 9u6in'% Die6 9en27h n769iu/$% Me/5e907n=78 8onsu/si /787n7n =7n /en7n2un 7s7/ >ol76 27n
0esi =7n 6ini.*% Menhin279i 8onsu/si 7l4ohol 27n 9o8o8+% Menin87687n 8onsu/si 7i9 5u6ih,% Menin87687n 8onsu/si susu 0e987lsiu/ !Di5i9o ,6h e23#"")%.)% Pe/0e9i7n 697ns>usi PRC% e/o2i7lisis
c. Tera+i ,ar"akologi
!a"a bat Dosis ,rekuensi n/ikasi
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
15/21
O# $;5/ -il72i5e9lu87n
Ses78 n757s357sien 6i278 s7279
In>us 2e69ose*
1" TPM in7 KRS Men7/07h ene9i
A/5i4illin #*" / 5.o # 1 An6i0io6i8 un6u8s7lu97n
5e9n757s7n
InBe8si 97n6in 1 A/5ul i #$ B7/ Men767si /u7l879en7 ESOA/5i4illin
-i4n76 # >l7sh 29i5 Asis2osis/e670oli8
A/lo2i5in 1" / #$ B7/ i5e96ensi3/enu9un87n TDhin7 1$";"//
Ce>69i78son 1 9 # #$ B7/ An6i0io6i8 se6el7he/o2i7lisis
e/o2i7lisis #;/inu Men7n6i >unsiinB7l
T97ns>. PRC -il72i5e9lu87n
Un6u8/enhil7n87n7ne/i7
!Di5i9o ,6h e23 #"")%.
/. 0onitoring
N7/7 O076 Moni6o9in T79e6Ke0e9h7sil7n
Ke0e9h7sil7n ESO
O# Ses783 RR Ti278 ses783 RR no9/7l
In>us 2e69ose
*
le/7s Ru7/
8uli63/u7l3
Ti278 le/7s
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
16/21
/un67h
A/5i4illin In>e8si O97lC7n2i2i7sis
In>e8si3 /onosi6/enu9un3
li/>osi6 n7i8
InBe8si 97n6in /u7l S78i6 8e57l738ons6i57si32i79e
Ti278 /u7l!/u7l 879en7ESO 7/5i4illin%
-i4n76 Asi2osis/e670oli8
E2e/73hi5o87le/i73/e670oli87l87losis
K7279 u9eu/no9/7l
A/lo2i5in TD3 CAD R7s7 h7us/enin8763>l76ulen3
TD no9/7l!1$";" //%
Ce>69i78son i In>e8si 0786e9i S78i6 8e57l730e98e9in7632i79e
Men4e7hin>e8si 0786e9i
e/o2i7lisis Funsi inB7l6e97n6i87n
CAD Funsi inB7l27576
6e97n6i87nT97ns>. PRC Ane/i7 Ren67n 2en7n
in>e8si 27n 7278on67/in7si
0786e9i
Ti278 7ne/i7
e. K1
1% KIE un6u8 6en77 8eseh767n: Se2i77n =7n 5e9lu 2iinBe8si87n 5727 57sien 727l7h A/5i4illin 27n
R7n6in Se2i77n -i4n76 5e/0e9i7nn=7 2il79u687n 27l7/ L79u67n De69ose
* *""44 Pe9lu 2il78u87n 5ene4e87n 9u6in U9eu/ 2797h3 7l0u/in3 03
leu8osi6. A570il7 6e9B72i e>e8 s7/5in3 /787 2il78u87n e7lu7si 5enun77n
o076
#% KIE un6u8 8elu797 57sien
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
17/21
C797 /inu/ o076 27n >9e8uensin=7. Me/5e9h76i87n 27n /enin7687n B72
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
18/21
Ce>l76oin 19 # 1 h79i An6i0io6i83In>e8si 6u9un
Di0e9i87nse6el7h Dun6u8/en4e7hin>e8si
T97n>usiPRC
Menhil7n87n;/enu9un87neB7l7 7ne/i7
Un6u8/enu9un87nMC(3 RDW3E9i69osi6
D. DISKUSI !Pe967n=77n 27n &769i78son 2en7n A/5i4illin
-77i/7n7 8esesu7i7n 2osisn=7 8e 57sien
&7 Benis coccus !8e07n=787n s5esies
streptococcus% 27n enterococcus. An6i0io6i8 =7n u/u/ 2iun787n
727l7h olon7n 4e>7los5o9in ene97si 8e6i7. Di/7n7 4e>69i78son =7n
2iun787n /7su8 27l7/ olon7n 27n ene97si 8e6i7 279i 4e>7los5o9in.P727 87sus 57sien 5e/0e9i7n 4e>69i78son 27n 7/5i4illin su27h 6e576
2i/7n7 2en7n 8o/0in7si 8e2u7 7n6i0io6i8 ini 2ih7975787n 787n
/enh7sil87n e>e8 6e975i =7n le0ih e>e86i> Bi87 2i07n2in87n 2en7n
5e/0e9i7n 67n57 8o/0in7si !Moo9e 7n2 Ai6h7l3 #""+%.
#. Al7s7n 5enun77n olu/e 4on69ol 9ein>usion 27n 077i/7n7 59oses
5el78s7n77nn=7
&779/78oloi 07i 57sien =7n /en2e9i67 massive refractory ascites, =7i6u
8on2isi 7s4i6es 5727 57sien su27h 6i278 27576 2i67n7ni l7i 2en7n
5enun77n 7en >79/78oloi. P7sien Ds9 2i0e9i87n 6e975i 7s4i6es 2en7n
/enun787n volume control reinfusion 879en7 6e975i 2en7n
/enun787n o076 olon7n 2iu9e6i8 un6u8 /e/0u7n 47i97n 7s4i6es
su27h 6i278 l7i e>e86i> 78i076 inB7l 57sien su27h 6i278 0e9>unsi 2en7n
07i8 sehin7 57sien 6i278 0is7 /ene8s89esi87n 47i97n 7s4i6es /es8i5un
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
19/21
su27h 2i0e9i87n 7en 2iu9e6i8. Volume control reinfusion /e9u5787n s7l7h
s76u 6e975i 5enelu797n 47i97n 7s4i6es =7n 6i278 27576 2i767si 2en7n
/enun787n he/o2i7lisis. Te975i ini 2il78u87n 0e9s7/77n 2en7n
he/o2i7lisis 2i/7n7 47i97n 7s4i6es 2i5o/5787n 8elu79 279i 9on7
5e9i6one7l 57sien /el7lui 2i7lise9 !su et al., #"11%.
E. KESIMPULAN
&72i 279i 87sus CRF 2en7n 7s4i6es o076 =7n 2iun787n un6u8
6e975in=7 =7i6u O8sien 2en7n 2osis $;65/ 0il7 2i5e9lu87n un6u8 ses78
7s/73 in>use 2e69os7 * 2osisn=7 1" TPM un6u8 /en7/07h ene9i3
A/5i4illin 2osisn=7 #*" / 5e9 o97l # #$ B7/ un6u8 7n6i0io6i83 inBe8si
97n6in 1 7/5ul i. 1 #$ B7/ un6u8 /en767si /u7l 879en7 ESO A/5i4illin3
-i4n76 2osisn=7 # >l7sh 29i5 un6u8 7si2osis /e670oli83 A/lo2i5in 2osisn=7 1"
/ 1 #$ B7/ un6u8 i5e96ensi !/enu9un87n 6e87n7n 2797h 1$";" //%3
Ce>69i78son 2osisn=7 1 97/ # #$ B7/ un6u8 7n6i0io6i8 se6el7h he/o2i7lisis3
e/o2i7lisis #;/inu un6u8 /en7n6i87n >unsi inB7l3 697ns>usi PRC
0il7 2i5e9lu87n un6u8 /enhil7n87n 7ne/i7. Se27n87n o076 =7n 6i278
2iun787n h7n=7 inBe8si L7si.
DAFTAR PUSTAKA
A8h/72i3 #"1$3 Penu8u97n T7n27 (i97l, UGM Journal: Yo=787967.
796/7n -3 e6 7l.3 #"1"3 D9u The975= in P76ien6s Wi6h Ch9oni4 Ren7l F7ilu9e3
tsc! "r#tebl $nt3 1", !',%.
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
20/21
Moo9e3 K.P.3 Ai6h7l3 G.P.3 #""+3 Gui%elines &n '!e Management &f "scites $nCirr!osis3 Unie9si6= Collee Me2i47l S4hool: Lon2on.
su3 e6 7l.3 #"113 Rein>usion o> As4i6es Du9in e/o2i7l=sis 7s 7 T9e76/en6 o>
M7ssie Re>9746o9= As4i6es 7n2 A4u6e Ren7l F7ilu9e3 $nt J ep!rol
Renovasc3 $: #''.
&NC)3 #"1$3 Ei2en4e-7se2 Gui2line >o9 M7n7e/en6 o> ih -loo2 P9essu9e
in A2ul6s3"merican Me%ical "ssociation.
S7n6os73 -u2i.3 #"",3an%uan iagnosa *epera+atan "" --/--03
P9i/7 Me2i87: &787967.
LAMPIRAN
-
7/25/2019 Laporan Praktikum Farmakoterapi II p.1 Ggk
21/21